Volume 5, Number 1—February 1999
Research
Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in Brazil
Artur Ramos*†, Amilcar Tanuri†, Mauro Schechter†, Mark A. Rayfield*, Dale J. Hu*, Maulori C. Cabral†, Claudiu I. Bandea*, James Baggs‡, and Danuta Pieniazek*
Table 2
p17/p24 gag, prt, and C2-V3 genetic subtyping of HIV-1 DNA sequencesa from peripheral blood mononuclear cells collected from 18 patients in Rio de Janeiro
| Genotypes |
|||||
|---|---|---|---|---|---|
| Specimen | No. | gag p17 | gag p24 | prt | C2-V3 |
| Group 1b | 8 | NDc | B | B | B |
| Group 2d | 4 | F | F | F | F |
| (BR46) | (NAe) | (B) | (F) | (F) | |
| (BR59) | (F) | (B) | (F) | (F) | |
| (BR57) | (F) | (B/F) | (F) | (F) | |
| (BR97) | (B) | (B/F) | (F) | (F) | |
| (BR60) | (B) | (B/F) | (F) | (B) | |
| (BR43) | (B) | (B) | (F) | (B) | |
aRecombinant specimens are shown in parentheses; B/F mosaic structure within a 311-bp of the p24 gag fragment consisting of subtypes B and F sequences.
bGroup 1: BR34, BR52, BR55, BR64, BR65, BR71, BR75, and BR92.
cND=not done.
dGroup 2: BR41, BR54, BR58, and BR112.
eNA = not available due to negative PCR.
Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.